Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia - NaturePropionic acidemia is a rare disorder with potentially life-threatening metabolic decompensation events.mRNA-3927 therapy showed promising results in reducing the risk of metabolic decompensation events in participants.